BANK OF AMERICA CORP /DE/ - DIAMEDICA THERAPEUTICS INC ownership

DIAMEDICA THERAPEUTICS INC's ticker is DMAC and the CUSIP is 25253X207. A total of 40 filers reported holding DIAMEDICA THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
BANK OF AMERICA CORP /DE/ ownership history of DIAMEDICA THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$6440
+1233.3%
0.00%
Q2 2022$030.0%0.00%
Q1 2022$030.0%0.00%
Q4 2021$0
-100.0%
3
-97.9%
0.00%
Q2 2021$1,0000.0%145
+113.2%
0.00%
Q1 2021$1,0000.0%68
-6.8%
0.00%
Q2 2020$1,00073
-65.4%
0.00%
Q3 2019$0
-100.0%
211
-96.4%
0.00%
Q4 2018$17,0005,9000.00%
Other shareholders
DIAMEDICA THERAPEUTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 1,197,245$2,993,0001.24%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 265,000$663,0000.40%
COOPERMAN LEON G 812,508$2,031,2700.11%
Ikarian Capital, LLC 221,252$553,0000.07%
Shay Capital LLC 10,000$25,0000.00%
Sandy Cove Advisors, LLC 1,200$3,0000.00%
BOOTHBAY FUND MANAGEMENT, LLC 20,603$52,0000.00%
Newbridge Financial Services Group, Inc. 1,269$3,0000.00%
Patriot Financial Group Insurance Agency, LLC 1,300$3,0000.00%
GROUP ONE TRADING, L.P. 20$00.00%
View complete list of DIAMEDICA THERAPEUTICS INC shareholders